Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Beneficial effects of vitamin C demonstrated in heart failure patients

Feb. 4, 1998

Hoechst reveals several series of Na+/H+ exchange inhibitors

Feb. 4, 1998

Second-generation DHEA derivative in development at Pharmadigm

Feb. 3, 1998

BASF presents new ET antagonists

Feb. 3, 1998

VasoCare approved in EU

Feb. 2, 1998

Mibefradil inhibits noradrenaline release via blockade of N-type Ca2+ channels

Feb. 2, 1998

BMS prepares MTP inhibitors for atherosclerosis and related diseases

Feb. 2, 1998

Caspase inhibitor reduces ischemia/reperfusion injury, attenuates apoptosis in vivo

Jan. 30, 1998

Tanabe's Tanatril receives E.U. approval

Jan. 30, 1998

Diosmetin derivatives for vascular disorders prepared at ADIR

Jan. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...